Synapse - Chau Dang

Results (273)

Survival benefit needed to undergo chemotherapy: Patients and physicians preferences

Meeting Abstract

Luis, I. V.; O'Neill, A.; Sepucha, K.; Miller, K. D.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Winer, E. P.; Sledge, G. W.; Schneider, B. P.; more...
Cancer Research (2016)

Fulltext@MSK | Save

Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
Cancer Research (2016)

Fulltext@MSK | Save

Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience

Meeting Abstract

Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
Cancer Research (2016)

Fulltext@MSK | Save

Cardiac safety of trastuzumab without an anthracycline in patients with HER2-positive early stage breast cancer: A single center experience

Meeting Abstract

Mukku, R. B.; Verma, S.; Liu, J.; Steingart, R.; Hudis, C.; Yu, A. F.; Dang, C.
Cancer Research (2016)

Fulltext@MSK | Save

Dermatologic adverse events associated with use of adjuvant lapatinib in combination with paclitaxel and trastuzumab for HER2-positive breast cancer: A case series analysis

Journal Article

Friedman, M. D.; Lacouture, M.; Dang, C.
Clinical Breast Cancer (2016)

Fulltext@MSK | Save

Cardiac outcomes of patients receiving adjuvant weekly paclitaxel and trastuzumab for node-negative, ERBB2-positive breast cancer

Journal Article

Dang, C.; Guo, H.; Najita, J.; Yardley, D.; Marcom, K.; Albain, K.; Rugo, H.; Miller, K.; Ellis, M.; Shapira, I.; more...
JAMA Oncology (2016)

Fulltext@MSK | Save

Cardiac safety of paclitaxel plus trastuzumab and pertuzumab in patients with HER2-positive metastatic breast cancer

Journal Article

Yu, A. F.; Manrique, C.; Pun, S.; Liu, J. E.; Mara, E.; Fleisher, M.; Patil, S.; Jones, L. W.; Steingart, R. M.; Hudis, C. A.; more...
The Oncologist (2016)

Fulltext@MSK | Save

Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: Getting to the heart of the matter

Journal Article

Dang, C. T.; Yu, A. F.; Jones, L. W.; Liu, J.; Steingart, R. M.; Argolo, D. F.; Norton, L.; Hudis, C. A.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: A report from the Childhood Cancer Survivor Study

Journal Article

Henderson, T. O.; Moskowitz, C. S.; Chou, J. F.; Bradbury, A. R.; Neglia, J. P.; Dang, C. T.; Onel, K.; Friedman, D. N.; Bhatia, S.; Strong, L. C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer

Journal Article

Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
Clinical Breast Cancer (2016)

Fulltext@MSK | Save